Eli Lilly

Bamlanivimab allocations to states and territories will be based on their number of hospitalised COVID-19 patients and the number…

The company had said earlier this month that it was applying for EUA for the antibody-drug, LY-CoV555, for patients with mild to…

They assured that they will work towards developing innovations to fight the COVID-19 pandemic, ensuring their timely availability…

Together, the companies hope to be able to produce many millions of doses even next year

Approximately 55 per cent of type T2D patients suffer from cardiovascular disease (CVD), which often leads to further…

Data from the Adaptive COVID-19 Treatment Trial (ACTT-2) revealed an approximately one-day reduction in median recovery time for…

The approval expands the label of once-weekly Trulicity to include 3.0 mg and 4.5 mg doses based on data from AWARD-11 trial

Olanzapine is indicated for the treatment of schizophrenia and bipolar disorder

Among the positive performances were Takeda Pharmaceutical and Daiichi Sankyo, which reported more than 100 per cent YoY growth in…

The commitments demonstrate the combined will of leading companies in the field to share scientific expertise, technical skills…